Gyntools provides GYNI- an AI-based accurate, rapid point-of-care diagnostic system for vaginitis, the most common gynecological problem that is misdiagnosed today in 50% of first clinic visits. The company's product is AMAR & CE approved and we started commercialization in Israel and Europe, while preparing for US FDA submission under 510(k) & CLIA waiver. GYNI has granted patents.